Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  anemia
Country:  U.S.A.
Trial Type:  Treatment
Results 1-7 of 7 for your search:
Start Over
Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Phase: Phase IV
Type: Treatment
Age: 2 and over
Trial IDs: LA38-0411, NCI-2014-01229, NCT02041299
Lenalidomide with or without Epoetin Alfa in Treating Patients with Myelodysplastic Syndrome and Anemia
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: E2905, NCI-2009-01173, CDR0000634119, ECOG-E2905, NCT00843882
Rituximab and Pentostatin or Bendamustine Hydrochloride in Treating Patients with Relapsed or Refractory Hairy Cell Leukemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 10-C-0025, NCI-2013-01455, P09576, NCT01059786
Sotatercept in Treating Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis or Anemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2012-0534, NCI-2012-03139, NCT01712308
Tumor Infiltrating Lymphocytes, Aldesleukin, and Chemotherapy in Treating Patients with Metastatic Melanoma
Phase: Phase II
Type: Treatment
Age: 18 to 66
Trial IDs: 14-C-0022, NCI-2014-02337, P131421, NCT01993719
Filgrastim-Stimulated Bone Marrow Transplant in Treating Patients with Hematological Malignancies without Matched Donors
Phase: No phase specified
Type: Treatment
Age: Under 22
Trial IDs: 21819, NCI-2014-01418, 0159-2004, 159-2004 (G-CSF PMRD Feasibility), CR6_IRB00021819, EMORY IRB # 21819, G-CSF PMRD, NCT00228813
Start Over